Appointment of Che-Kai Tsao, MD, as Medical Director of Ruttenberg Treamtent Center
Thursday, January 19, 2017
Posted by: Julie Briggs
We are very pleased to share the appointment of Che-Kai Tsao, MD, as Medical Director of Ruttenberg Treatment Center at the Tisch Cancer Institute, Mount Sinai Hospital. He assumed his new role effective January 1, 2017.
Dr. Che-Kai Tsao received his medical degree from SUNY Downstate College of Medicine. He then completed a residency in Internal Medicine at Long Island Jewish Medical Center of Albert Einstein College of Medicine and underwent fellowship training in Hematology-Oncology at Mount Sinai Medical Center in 2009. He served as chief fellow and led several initiatives to promote fellowship education and academic excellence. In 2011, he was chosen for the ASCO/AACR Workshop on Methods in Clinical Cancer Research award. He was recognized with the 2012 Mount Sinai Fellow Physician of the Year and subsequently recruited to our division as an Assistant Professor of Hematology and Medical Oncology, with a focus in clinical and translation research in genitourinary cancers.
Academically, Dr. Tsao is actively involved in research on identifying prognostic and predictive biomarkers, as well as the development of novel therapies in the treatment of genitourinary cancers. He was the recipient of the 2011 ASCO trainee award, 2012 ASCO genitourinary cancers merit award, and the 2012 ASCO merit award. He has published over 40 peer reviewed manuscripts. He is currently the principal investigator of several active clinical trials at the Tisch Cancer Institute. He was the co-chair of the 2013 ASCO prostate cancer poster discussion session. He is a reviewer for several peer review journals, and has been invited to share his expertise regarding the treatment of genitourinary cancer regularly.
As a clinical leader, Dr. Tsao has had a pivotal role in the establishment and development of the Mount Sinai Queens Cancer Center, the first satellite facility of the Mount Sinai Cancer Network. In short order, the MSQ Cancer Center has become an important component of our Queens campus and of the Tisch Cancer Insititute. The center has consistently attain high levels of patient satisfaction and is model of success in patient-centered oncologic care and integration with the overall mission of TCI. Dr. Tsao brings this energy, enthusiasm and vision to the Ruttenberg Treatment Center.